Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Hollema

Showing results (41-50 of 131) with videos related to

Pageof 14
Sort By:
BMC Cancer|May 29, 2009
Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinomaLiqiang Qi, Joost Bart, Lu Ping Tan, et al.
Breast Cancer Research : BCR|June 14, 2012
Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countriesMichael E Jones, Flora E van Leeuwen, Wilhelmina E Hoogendoorn, et al.
Cancer|December 12, 2003
The value of routine follow-up in patients treated for carcinoma of the vulvaMaaike H M Oonk, Joanne A de Hullu, Harry Hollema, et al.
The Lancet. Oncology|July 11, 2002
An oncological view on the blood-testis barrierJoost Bart, Harry J M Groen, Winette T A van der Graaf, et al.
Pathology Oncology Research : POR|September 4, 2019
Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare CancersMarloes A M Peters, Coby Meijer, Rudolf S N Fehrmann, et al.
Gynecologic Oncology|June 7, 2012
Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinomaRenske A de Jong, Ido P Kema, Annemarie Boerma, et al.
The Journal of Pathology|December 21, 2010
TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cellsDianne M Heijink, Mathilde Jalving, Dorenda Oosterhuis, et al.
Cancer|November 19, 2002
Vulvar carcinoma. The price of less radical surgeryJoanne A De Hullu, Harry Hollema, Sietske Lolkema, et al.
Journal of Neuro-Oncology|March 18, 2006
TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiformeJos M A Kuijlen, Jan Jakob A Mooij, Inge Platteel, et al.
Histopathology|October 12, 2013
Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classificationJaume Ordi, Christine Bergeron, David Hardisson, et al.
Pageof 14

Showing results (41-50 of 131) with videos related to

Sort By:
Pageof 14
BMC Cancer|May 29, 2009
Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinomaLiqiang Qi, Joost Bart, Lu Ping Tan, et al.
Breast Cancer Research : BCR|June 14, 2012
Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countriesMichael E Jones, Flora E van Leeuwen, Wilhelmina E Hoogendoorn, et al.
Cancer|December 12, 2003
The value of routine follow-up in patients treated for carcinoma of the vulvaMaaike H M Oonk, Joanne A de Hullu, Harry Hollema, et al.
The Lancet. Oncology|July 11, 2002
An oncological view on the blood-testis barrierJoost Bart, Harry J M Groen, Winette T A van der Graaf, et al.
Pathology Oncology Research : POR|September 4, 2019
Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare CancersMarloes A M Peters, Coby Meijer, Rudolf S N Fehrmann, et al.
Gynecologic Oncology|June 7, 2012
Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinomaRenske A de Jong, Ido P Kema, Annemarie Boerma, et al.
The Journal of Pathology|December 21, 2010
TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cellsDianne M Heijink, Mathilde Jalving, Dorenda Oosterhuis, et al.
Cancer|November 19, 2002
Vulvar carcinoma. The price of less radical surgeryJoanne A De Hullu, Harry Hollema, Sietske Lolkema, et al.
Journal of Neuro-Oncology|March 18, 2006
TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiformeJos M A Kuijlen, Jan Jakob A Mooij, Inge Platteel, et al.
Histopathology|October 12, 2013
Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classificationJaume Ordi, Christine Bergeron, David Hardisson, et al.
Pageof 14